Plaintiffs Jamie H. and Byron H. are the latest to file a lawsuit filed against Boston Scientific Corporation over a transvaginal mesh procedure.

They both allege that the pelvic mesh sling used in the transvaginal mesh procedure is defective and that the manufacturers knew about this or should have known and failed to disclose the risk profile to the medical community or to potential patients.

The product named in the lawsuit is the Solyx sling system, but the plaintiffs also any other unnamed BSC pelvic mesh products that were sold for similar purposes.

The lawsuit argues that the defendant in this case purposely chose to manipulate studies conducted on their products leading to false and misleading information about the effectiveness and safety of the pelvic mesh slings.

According to the plaintiffs, the defendant knew that their pelvic mesh products were defective and that the materials used to develop the sling are biologically incompatible with human tissue. The lawsuit alleges that the polypropylene mesh causes a severe immune response in patients due to inflammation of the pelvic tissue.

Over time, according to the lawsuit, this can lead to severe adverse reactions with the mesh.

Plaintiff Jamie H. says she went through the surgical procedure in Arizona on Nov. 28, 2016 in which she received the BSC Solyx sling system. The purpose of that procedure was to address her stress urinary incontinence, which is the primary purpose of this medical device.

Jamie alleges that she experienced severe symptoms after implantation including leg and pelvic pain, impaired mobility, urgency of urination, voiding dysfunction, infections, and life-altering pain syndrome. The removal surgery for that transvaginal mesh sling occurred on Dec. 19th, 2007, she says.

The operative report associated with that surgery allegedly indicates that the procedure was more complicated than expected because the mesh was adhered to surrounding tissues.

According to the Merck Manual, transvaginal mesh products are usually used to treat pelvic floor disorders. Pelvic floor disorders include a dropping down of the bladder, small intestines, urethra, uterus, rectum or vagina due to weakness or injury to those ligaments, muscles of the pelvis or connective tissue. Women who are most likely to receive the surgical mesh are those who have been diagnosed with pelvic organ prolapse or stress urinary incontinence.

Pelvic organ prolapse occurs when the ligaments and muscles supporting a women’s pelvic organs become weaker, according to the Mayo Clinic. Stress urinary incontinence is associated with unintentional urine loss due to activity or physical movement.

Women who experience problems after mesh implantation should speak with their doctors about options. Some of the most common side effects include painful urination, vaginal bleeding, a recurrent urinary tract infection, and increased urgency for urination.

Some women like Jamie H. have taken to the courts in an effort to hold the manufacturer responsible for injuries allegedly tied to the mesh implants. These women argue that the maker of the device could have done more to warn about the dangers.

The Transvaginal Mesh Procedure Lawsuit is Case No. 2:19-cv-00422-DMF in the U.S. District Court for the District of Arizona.